ViaCyte

ViaCyte

Develops cell replacement therapies for diabetes. ViaCyte was acquired by Vertex Pharmaceuticals in 2022.

True North Therapeutics

True North Therapeutics

Focused on developing treatments for rare diseases mediated by the complement system. Acquired by Bioverativ in 2017.

Trilumina

Trilumina

Developed high-power semiconductor laser technology for automotive, industrial, and consumer applications, including LiDAR systems. Acquired by Lumentum in 2019.